Newsworthy articles with a focus on the Middle East & Africa

January 2019


see the full archive

Algerian German Partnership hypertension drugs

Algerian-German partnership agreement to produce hypertension, diabetes drugs

A €20 million partnership agreement was signed in Algiers between the Algerian-Turkish Abdi Ibrahim Remede Pharma (AIRP) and the German pharmaceutical company Boehringer Ingelheim for the production of hypertension and diabetes drugs in Algeria.
Julphar Dutch PharmaMarch

Julphar inks Dutch deal to bring new medicine to the UAE

UAE-based Julphar, one of the largest pharmaceutical manufacturers in the Middle East and Africa, has completed a deal with Dutch company PharmaMatch to launch a combination for the treatment of hypercholesterolemia, which is currently unavailable in the UAE market.
EAEF Dawi Egypt

EAEF to inject $3m into Dawi’s medical base Maharram law Group

The Egyptian American Enterprise Fund (EAEF) and Dawi clinics announced that the EAEF will inject $3m into Dawi’s medical base, describing it as a strategic step to support the growth of Egypt’s health sector.
UAE NMC Saudi Hassana Investment

UAE’s NMC, Saudi Hassana Investment ink SAR 6bn healthcare deal

UAE-based NMC Health has signed a memorandum of understanding (MoU) with Hassana Investment Company, the investment arm of Saudi Arabia’s General Organization for Social Insurance (GoSI), for healthcare investments worth as much as SAR 6 billion ($1.60 billion).

Report on Pharmaceutical Sales Representatives across Africa

Infomineo supported a client in finding data on the average qualification level, compensation package, and availability of pharmaceutical sales representatives in 23 African countries.

Learn more about the case study → 


UAE's Mubadala buys Abu Dhabi healthcare provider

Mubadala Investment Company, through its healthcare subsidiary, has announced the acquisition of Amana Healthcare, a provider of long-term care, specialized rehabilitation, and home healthcare services.

Lancet Laboratories merge Africa operations with Cerba HealthCare

Medical laboratory services provider Lancet Laboratories and its leading counterpart in Europe Cerba HealthCare have merged operations in a joint Venture. Cerba Lancet Africa will now manage a network of more than 100 laboratories previously owned by Lancet across 11 African countries including Kenya, with over 1,400 employees serving more than 1.3 million patients a year.
mylan (1)

Pharmaceutical giant Mylan acquires ARV drugs manufacturing plant in SA

Global pharmaceutical company Mylan announced the acquisition of a manufacturing site, previously owned by Ascendis Health, for its plans to produce high-quality antiretrovirals for 7 million South Africans living with HIV.

Meraas Dubai BHSSCI-at-Valiant-Clinic Dubai (1)

Meraas launches Beverly Hills Sunset Surgery Center International at Valiant Clinic, City Walk Dubai

Meraas has announced the official opening of Beverly Hills Sunset Surgery Center International (BHSSCI), to bring to the UAE some of the world’s most celebrated names and faces in comprehensive plastic and aesthetic surgery
Moi Referral Hospital

Moi Referral to build Africa's largest hospital

Eldoret-based Moi Teaching and Referral Hospital has sought approval to build Africa’s largest hospital with 4,000 beds to service western Kenya’s 24 million people. According to regulatory filings, the Sh28 billion project, earmarked for construction on 200 acres at Kiplombe on the outskirts of Eldoret town, will complement services offered at its current multi-specialty 1,000-bed centre on Nandi Road.
Aspen South Africa Port Elizabet

Aspen Pharmacare to build $235M production facility in South Africa, add hundreds of jobs

Aspen Pharmacare says it will invest nearly $235 million in a facility to manufacture sterile anesthetics. Stavros Nicolaou, Aspen senior executive, said that the R3.4 billion facility would be built at its Port Elizabeth manufacturing site and that it offered a high tech manufacturing niche “that presents both domestic and export opportunities.”
Pharmax Dubai

Pharma firm inaugurates $34m Dubai manufacturing plant

Dubai Science Park welcomes the launch of its first pharmaceutical manufacturing plant. Operated by Pharmax Pharmaceuticals (Pharmax), the AED125 million ($34 million) factory will have an annual production capacity of over 200 million tablet and capsules. Pharmax said it is dedicated to the manufacturing and commercialization of pharmaceuticals that target chronic conditions prevalent in the Middle East.
Ekity Dubai Momdia Group

Ekiti Partners Dubai Firm On Child Health Service

The Ekiti State Government (Nigeria) signed a strategic partnership with a leading mobile technology firm based in Dubai, Momdia Group, for the roll out of a new mobile child health service. The partnership, which will be launched in two phases, would commence with the first phase: “Mum & Baby,” a maternal and health support service, and the digitization of the Child Health Card.
Dubai Robot Smart Pharmacy

Dubai inaugurates new robot pharmacy as network grows

Dubai Health Authority (DHA) inaugurated a smart pharmacy featuring a robot for dispensing and prescribing medication in Latifa Hospital. This is the fourth of its kind in the DHA, as the authority launched two smart pharmacies at Rashid Hospital and one in Dubai Hospital early in 2018.

Nigeria launch intensifies roll-out of Lumify with Reacts tele-ultrasound in Africa

Philips has launched its highly innovative Lumify with Reacts mobile tele-ultrasound solution in Nigeria at Medic West Africa. Lumify with Reacts connects clinicians around the globe in real time by turning a compatible smart device into an integrated tele-ultrasound system, combining two-way audio-visual calls with live ultrasound streaming.

287279-P6KATQ-650 (1)

KSA’s Vision 2030 on Establishing an Empowering Healthcare System

In April 2016, Saudi Arabia presented its vision for a “vibrant society, a thriving economy and an ambitious nation.” The Kingdom wants its citizens to live longer – from now expected 74 years to 80 years.
Conception sans titre (1)

Target screening support in the due diligence process of an acquisition

A large multinational pharmaceutical group considering the acquisition of a Moroccan firm that owns a manufacturing or import license.
Explore the full library




Infomineo is a data and research service provider, that specializes in Africa and the Middle East, dedicated to supporting global companies in getting access to information that powers their investment decisions in the region. Through a direct presence in key markets such as the UAE, South Africa, Kenya, Egypt and Morocco, Infomineo provides a quick access to market data on key questions such as: market and product prioritization, partner identification, commercial due diligence, route to market, supply chain mapping and competitive analysis among others. Along with conducting custom research for clients, Infomineo also delivers an Expert Network service, an Executive Search service, and a Business Translation service. 

Learn about Infomineo
Copyright © 2018 Infomineo, All rights reserved.
Infomineo is a research provider. Our role is to find the data our clients need to take decisions and develop their businesses.
Our global coverage and unique expertise on Africa and the Middle East allow us to develop long-term relationships
with leading global consulting firms and Fortune 500 companies.
Our mailing address is: INFOMINEO, Business Center - Dubai World Central, Dubai, PO Box 390667 
You received this email because you are subscribed to Healthcare Newsletter from INFOMINEO.
Update your email preferences